Birthe Gericke - Search Results

Year	Number of Results
2013	1
2016	1
2017	2
2018	1
2019	3
2020	6
2021	4
2022	1

1

A mutation map for human glycoside hydrolase genes.

Hansen L, Husein DM, Gericke B, Hansen T, Pedersen O, Tambe MA, Freeze HH, Naim HY, Henrissat B, Wandall HH, Clausen H, Bennett EP. Hansen L, et al. Among authors: gericke b. Glycobiology. 2020 Jul 16;30(8):500-515. doi: 10.1093/glycob/cwaa010. Glycobiology. 2020. PMID: 32039448 Free PMC article.

2

Effects of the NKCC1 inhibitors bumetanide, azosemide, and torasemide alone or in combination with phenobarbital on seizure threshold in epileptic and nonepileptic mice.

Hampel P, Römermann K, Gailus B, Johne M, Gericke B, Kaczmarek E, Löscher W. Hampel P, et al. Among authors: gericke b. Neuropharmacology. 2021 Mar 1;185:108449. doi: 10.1016/j.neuropharm.2021.108449. Epub 2021 Jan 12. Neuropharmacology. 2021. PMID: 33450274

3

Novel Intrinsic Mechanisms of Active Drug Extrusion at the Blood-Brain Barrier: Potential Targets for Enhancing Drug Delivery to the Brain?

Löscher W, Gericke B. Löscher W, et al. Among authors: gericke b. Pharmaceutics. 2020 Oct 14;12(10):966. doi: 10.3390/pharmaceutics12100966. Pharmaceutics. 2020. PMID: 33066604 Free PMC article. Review.

4

Deletion of the Na-K-2Cl cotransporter NKCC1 results in a more severe epileptic phenotype in the intrahippocampal kainate mouse model of temporal lobe epilepsy.

Hampel P, Johne M, Gailus B, Vogel A, Schidlitzki A, Gericke B, Töllner K, Theilmann W, Käufer C, Römermann K, Kaila K, Löscher W. Hampel P, et al. Among authors: gericke b. Neurobiol Dis. 2021 May;152:105297. doi: 10.1016/j.nbd.2021.105297. Epub 2021 Feb 11. Neurobiol Dis. 2021. PMID: 33581254 Free article.

5

A combination of phenobarbital and the bumetanide derivative bumepamine prevents neonatal seizures and subsequent hippocampal neurodegeneration in a rat model of birth asphyxia.

Johne M, Käufer C, Römermann K, Gailus B, Gericke B, Löscher W. Johne M, et al. Among authors: gericke b. Epilepsia. 2021 Jun;62(6):1460-1471. doi: 10.1111/epi.16912. Epub 2021 May 6. Epilepsia. 2021. PMID: 33955541

6

Similarities and differences in the localization, trafficking, and function of P-glycoprotein in MDR1-EGFP-transduced rat versus human brain capillary endothelial cell lines.

Gericke B, Borsdorf S, Wienböker I, Noack A, Noack S, Löscher W. Gericke B, et al. Fluids Barriers CNS. 2021 Aug 3;18(1):36. doi: 10.1186/s12987-021-00266-z. Fluids Barriers CNS. 2021. PMID: 34344390 Free PMC article.

7

The multiple roles of sucrase-isomaltase in the intestinal physiology.

Gericke B, Amiri M, Naim HY. Gericke B, et al. Mol Cell Pediatr. 2016 Dec;3(1):2. doi: 10.1186/s40348-016-0033-y. Epub 2016 Jan 26. Mol Cell Pediatr. 2016. PMID: 26812950 Free PMC article.

8

Proof-of-concept that network pharmacology is effective to modify development of acquired temporal lobe epilepsy.

Schidlitzki A, Bascuñana P, Srivastava PK, Welzel L, Twele F, Töllner K, Käufer C, Gericke B, Feleke R, Meier M, Polyak A, Ross TL, Gerhauser I, Bankstahl JP, Johnson MR, Bankstahl M, Löscher W. Schidlitzki A, et al. Among authors: gericke b. Neurobiol Dis. 2020 Feb;134:104664. doi: 10.1016/j.nbd.2019.104664. Epub 2019 Nov 1. Neurobiol Dis. 2020. PMID: 31678583 Free article.

9

Selective inhibition of mTORC1/2 or PI3K/mTORC1/2 signaling does not prevent or modify epilepsy in the intrahippocampal kainate mouse model.

Gericke B, Brandt C, Theilmann W, Welzel L, Schidlitzki A, Twele F, Kaczmarek E, Anjum M, Hillmann P, Löscher W. Gericke B, et al. Neuropharmacology. 2020 Jan 1;162:107817. doi: 10.1016/j.neuropharm.2019.107817. Epub 2019 Oct 22. Neuropharmacology. 2020. PMID: 31654704

10

Novel brain permeant mTORC1/2 inhibitors are as efficacious as rapamycin or everolimus in mouse models of acquired partial epilepsy and tuberous sclerosis complex.

Theilmann W, Gericke B, Schidlitzki A, Muneeb Anjum SM, Borsdorf S, Harries T, Roberds SL, Aguiar DJ, Brunner D, Leiser SC, Song D, Fabbro D, Hillmann P, Wymann MP, Löscher W. Theilmann W, et al. Among authors: gericke b. Neuropharmacology. 2020 Dec 1;180:108297. doi: 10.1016/j.neuropharm.2020.108297. Epub 2020 Sep 3. Neuropharmacology. 2020. PMID: 32890589

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results